Twist Bioscience (TWST) Cash from Investing Activities Growth (3y) (2020 - 2026)
Analysis
Twist Bioscience (TWST) Cash from Investing Activities Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 33.33% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -186.61% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -126.34% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -48.84% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 81.69% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -14.06% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -63.66% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | -26.67% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -20.13% |
| 10 | Twist Bioscience | 8.93 Bn | 8.76 Bn | 62.45 Mn | -36.55% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -36.55% |
| Mar 31, 2026 | -32.17% |
| Dec 31, 2025 | -12.53% |
| Sep 30, 2025 | -86.21% |
| Jun 30, 2025 | -62.07% |
| Mar 31, 2025 | 52.49% |
| Dec 31, 2024 | 81.07% |
| Sep 30, 2024 | -27.11% |
| Jun 30, 2024 | -26.13% |
| Mar 31, 2024 | -27.47% |
| Dec 31, 2023 | 27.87% |
| Sep 30, 2023 | 71.26% |
| Jun 30, 2023 | 32.10% |
| Mar 31, 2023 | 12.69% |
| Dec 31, 2022 | -36.83% |
| Sep 30, 2022 | 63.17% |
| Jun 30, 2022 | 29.73% |
| Mar 31, 2022 | 4.28% |
| Dec 31, 2021 | -51.04% |
| Sep 30, 2021 | 289.71% |